A Prospective Multicentre Surveillance Study to Investigate the Risk Associated with Contaminated Sinks in the Intensive Care Unit
Overview
Authors
Affiliations
Objectives: The aim was to assess the incidence of sink contamination by multidrug-resistant (MDR) Pseudomonas aeruginosa and Enterobacteriaceae, risk factors for sink contamination and splashing, and their association with clinical infections in the intensive care setting.
Methods: A prospective French multicentre study (1 January to 30 May 2020) including in each intensive care unit (ICU) a point-prevalence study of sink contamination, a questionnaire of risk factors for sink contamination (sink use, disinfection procedure) and splashing (visible plashes, distance and barrier between sink and bed), and a 3-month prospective infection survey.
Results: Seventy-three ICUs participated in the study. In total, 50.9% (606/1191) of the sinks were contaminated by MDR bacteria: 41.0% (110/268) of the sinks used only for handwashing, 55.3% (510/923) of those used for waste disposal, 23.0% (62/269) of sinks daily bleached, 59.1% (126/213) of those daily exposed to quaternary ammonium compounds (QACs) and 62.0% (285/460) of those untreated; 459 sinks (38.5%) showed visible splashes and 30.5% (363/1191) were close to the bed (<2 m) with no barrier around the sink. MDR-associated bloodstream infection incidence rates ≥0.70/1000 patient days were associated with ICUs meeting three or four of these conditions, i.e. a sink contamination rate ≥51%, prevalence of sinks with visible splashes ≥14%, prevalence of sinks close to the patient's bed ≥21% and no daily bleach disinfection (6/30 (20.0%) of the ICUs with none, one or two factors vs. 14/28 (50.0%) of the ICUs with three or four factors; p 0.016).
Discussion: Our data showed frequent and multifactorial infectious risks associated with contaminated sinks in ICUs.
Zhu W, Liang Y, Xu J, Weng C Infect Drug Resist. 2025; 18:757-768.
PMID: 39931038 PMC: 11809232. DOI: 10.2147/IDR.S506658.
Fucini G, Abe R, Lemke E, Gastmeier P Antimicrob Resist Infect Control. 2024; 13(1):137.
PMID: 39551779 PMC: 11571737. DOI: 10.1186/s13756-024-01493-3.
Wei L, Feng Y, Lin J, Kang X, Zhuang H, Wen H Front Public Health. 2024; 12:1468521.
PMID: 39444981 PMC: 11496070. DOI: 10.3389/fpubh.2024.1468521.
Stoesser N, George R, Aiken Z, Phan H, Lipworth S, Quan T JAC Antimicrob Resist. 2024; 6(5):dlae140.
PMID: 39234218 PMC: 11369815. DOI: 10.1093/jacamr/dlae140.
Outbreak of on a neonatal intensive care unit: Lessons from a Qatari setting.
Petkar H, Caseres-Chiuco I, Al-Shaddad A, Mohamed M, Ahmed I, Rao R J Infect Prev. 2024; 25(4):103-109.
PMID: 39055679 PMC: 11268246. DOI: 10.1177/17571774241236248.